Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.
about
Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulationHIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activityHypoxia and Hypoxia-Inducible Factors in LeukemiasHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionHIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progressionGLUT1 gene is a potential hypoxic marker in colorectal cancer patients.Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patientsHIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumThe absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody.Hypoxia and lineage specification of cell line-derived colorectal cancer stem cellsIdentification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer.HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs.Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis.HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells.Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinomaA critical role of mir-199a in the cell biological behaviors of colorectal cancerPrognostic impacts of hypoxic markers in soft tissue sarcomaRole and mechanism of hypoxia-inducible factor-1 in cell growth and apoptosis of breast cancer cell line MDA-MB-231Increased WNT6 expression in tumor cells predicts unfavorable survival in esophageal squamous cell carcinoma patientsMetabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cellsThe role of hypoxia-inducible factor-2 in digestive system cancers.Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer.Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectumThe "Sharp" blade against HIF-mediated metastasis.Antiangiogenic therapy in human gastrointestinal malignancies.Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomasHypoxia-inducible factors: central regulators of the tumor phenotype.Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings.The role of hypoxia-inducible factors in tumorigenesis.HIF-1alpha and HIF-2alpha have divergent roles in colon cancer.Advances in glucose metabolism research in colorectal cancerThe biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis.Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.HAF : the new player in oxygen-independent HIF-1alpha degradation.mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.
P2860
Q24298432-140224F3-9E1D-4684-ADAE-2977D7FAF8A7Q24302129-9CCF77B6-E27D-4BBA-B369-A7127F098C49Q26767167-52E3AD39-EB3A-4697-A9A5-DFF3D3661766Q27025886-71C6818D-46CD-4192-8AA3-4ECC3724ADBAQ27851557-151F24C4-F22F-4BC9-8AA2-64F32C94C10BQ33382510-5C32FEC0-BC7C-4264-A526-7A77097BC0A9Q33484365-9536DB6D-7515-470F-BFC4-B627828B8727Q34029008-999657F0-FBEE-4834-AF93-79091BFFA3F8Q34198666-1241B119-0912-454E-9935-A63C79599623Q34357465-03EA6B48-4CAE-4B57-9D9A-C39AB22BB34AQ34529351-4A83AB3D-AE8D-46B1-8E8E-7C2253E67CE8Q34693614-9868762F-F27C-41B2-B9A9-72569486FDCCQ35030421-B900138C-79C2-427B-BFAD-A70E445976C2Q35051166-223B06AA-ADB0-4C20-9D80-39F669061C28Q35063723-4F1012E0-D4EE-4414-93A9-8F072E81B73EQ35552029-E899F02D-2F6E-441D-B682-634BC52ECA8DQ35621236-5C40BEAC-4FF1-4FF3-89DC-A780F16DBDB6Q35770163-6B783844-30C4-404D-B571-B82DF494A4A6Q35789146-62FF1AC4-9815-4285-A1F4-0E6E5A0F87EBQ36216542-2C3F6D7F-93B3-4FFF-98B5-85426DDD6B79Q36261828-60AD2CB7-E891-46D4-8B24-D7EF3BC50E39Q36304128-64CE0342-6D77-429C-A0AF-C14F7A22766CQ36347140-2D5EAF3E-3F47-4D17-AA0D-8DBE1B977F0AQ36494154-95BA5F09-491E-41D1-A19B-A0E91C27F73DQ36524617-5CA6C358-B23F-45D9-9F31-DC2DDF684BB7Q36579500-535AAC29-7F84-48B6-A9BE-AFE2119317E0Q36581657-C6FBF6EC-5EB4-4EE8-8E5A-B5D9780929B7Q36591067-FE214DA4-E911-4311-B2B5-0498FE961151Q36610552-F4F2461D-C0CA-475A-8E86-C4F3F5430D1EQ36701590-FEE3EF2E-CEBC-4027-B1DB-3DE73F2E3DACQ36841746-DE71F38D-406B-42D0-A58C-1E0879A0E966Q37079708-F801590E-93F7-4A93-A587-EC5343835733Q37192848-6BD00AE3-22CD-4371-AC04-D526D9269AA3Q37204593-7E7EF093-16C1-44D1-9D0D-867D2D194E6EQ37210542-F0D804CF-F92A-463E-9C23-0FDA8EA9BBFDQ37228454-831212A1-5200-461A-9DB4-D60E5EDED014Q37249932-60BE241A-6707-4366-98E5-98A11A155304Q37424106-BC591993-BC8D-4795-B040-B907E80D5C9EQ37450692-B6FE4FC1-581F-48F9-8D4C-5BADA51FFDC3Q37451552-47677BDA-DB15-4AFE-8B36-8DA5944BC0A3
P2860
Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prognostic impact of hypoxia-i ...... d cyclooxygenase-2 expression.
@en
Prognostic impact of hypoxia-i ...... d cyclooxygenase-2 expression.
@nl
type
label
Prognostic impact of hypoxia-i ...... d cyclooxygenase-2 expression.
@en
Prognostic impact of hypoxia-i ...... d cyclooxygenase-2 expression.
@nl
prefLabel
Prognostic impact of hypoxia-i ...... d cyclooxygenase-2 expression.
@en
Prognostic impact of hypoxia-i ...... d cyclooxygenase-2 expression.
@nl
P2093
P921
P1476
Prognostic impact of hypoxia-i ...... d cyclooxygenase-2 expression.
@en
P2093
Dipok Kumar Dhar
Hirofumi Kubota
Hiroshi Yoshimura
Hitoshi Kohno
Mitsuo Tachibana
Naofumi Nagasue
Shoichi Kinugasa
Shuhei Ueda
Toshiyuki Fujii
P304
P356
10.1158/1078-0432.CCR-0946-03
P407
P577
2004-12-01T00:00:00Z